市場調查報告書
商品編碼
1422657
微創手術器械市場 - 產品(手持式器械、導引裝置、電外科裝置、輔助裝置)、手術類型(心胸、胃腸、骨科、婦科)、最終用途和預測,2024-2032年Minimally Invasive Surgical Instrument Market - Product (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices), Surgery Type (Cardiothoracic, Gastrointestinal, Orthopedic, Gynecological), End-use & Forecast, 2024-2032 |
由於醫療領域的技術進步,預計 2024 年至 2032 年微創手術器材市場的CAGR將超過 8.1%。全球慢性病盛行率的不斷上升和人口老化的不斷加劇,推動了對侵入性更小、更快、更安全的手術干預的需求。
根據聯合國《世界人口展望》,到2022年,65歲以上人口接近7.71億,幾乎佔全球總人口的10%。到2050年,老年人口比例預計將增加,達到總人口的16%。老年人更容易患各種慢性疾病和生活方式疾病。他們選擇恢復時間快的微創手術,增加了相關手術器械的需求。
微創手術器械市場根據產品、手術類型、最終用途和地區進行分類。
預計到 2032 年,骨科手術領域對這些儀器的需求將會強勁,因為它們正在改變關節置換、關節鏡檢查和脊椎手術的模式。對更快恢復時間、減少術後疼痛和更小切口的需求推動了這些器械在骨科手術中的採用。外科醫生和患者受益於精確度的提高和組織破壞的最小化,這標誌著骨科手術實施方式的範式轉變。
預計到 2032 年,門診手術中心 (ASC) 領域將大幅成長。ASC 提供的效率和成本效益使其成為對患者和醫療保健提供者都有吸引力的選擇。微創手術與 ASC 的目標完美契合,提供了縮短週轉時間、提高患者吞吐量並降低整體醫療成本的機會。 ASC 致力於確保更廣泛的患者群體更容易接受微創手術。
由於強大的醫療基礎設施和積極主動的技術整合,歐洲微創手術器材產業規模將在 2023 年至 2032 年期間大幅擴大。對先進技術的日益接受,加上門診手術需求的不斷成長,推動了產品需求。歐洲的支持性監管框架將為該地區的領導企業創造巨大的成長機會。
Minimally Invasive Surgical Instrument Market is anticipated to witness more than 8.1% CAGR between 2024 and 2032 owing to the technological advancements in medical sector. The increasing prevalence of chronic diseases and a growing aging population worldwide are propelling the need for less invasive, quicker, and safer surgical interventions.
As per the UN World Population Prospects, in 2022, there were nearly 771 million people aged 65 years or older which was almost 10% of the total global population. By 2050, the geriatric proportion is expected to increase, reaching 16% of the total population. The elderly are more susceptible to various chronic and lifestyle ailments. They opt for minimally invasive procedures with quick recovery time, bolstering the demand for related surgical instruments.
The minimally invasive surgical instruments market is classified based on product, surgery type, end-use, and region.
The orthopedic surgery segment is expected to record strong demand for these instruments through 2032 as they are transforming the landscape of joint replacements, arthroscopy, and spine surgeries. The demand for quicker recovery times, reduced postoperative pain, and smaller incisions has fueled the adoption of these instruments in orthopedic surgeries. Surgeons and patients are benefiting from enhanced precision and minimal tissue disruption, marking a paradigm shift in the way orthopedic procedures are performed.
The ambulatory surgical centers (ASCs) segment is anticipated to witness substantial growth through 2032. The efficiency and cost-effectiveness offered by ASCs make them an attractive option for both patients and healthcare providers. Minimally invasive procedures align perfectly with the goals of ASCs, providing the opportunity for quicker turnaround times, increased patient throughput, and reduced overall healthcare costs. The ASCs strive to ensure minimally invasive procedures are more accessible to a broader patient base.
Europe minimally invasive surgical instruments industry size will expand significantly over 2023-2032, due to robust healthcare infrastructure and a proactive approach towards technological integration. The growing acceptance of advanced technologies, coupled with the rising demand for outpatient procedures, fuel the product demand. The supportive regulatory frameworks in Europe will create massive growth opportunities for leading players in the region.